Related Experiment Video
Updated: May 8, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.1K
The Society of Thoracic Surgeons National Intermacs Database Risk Model for Durable Left Ventricular Assist Device
Francis D Pagani1, Brandon Singletary2, Ryan Cantor2
1Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.
The Annals of Thoracic Surgery
|January 26, 2025
Summary
A new risk model for durable left ventricular assist device (LVAD) implantation shows good performance. This tool can help select patients, improve care quality, and evaluate provider performance for LVAD procedures.
Area of Science:
- Cardiology
- Medical Statistics
- Health Services Research
Background:
- Statistical risk models are crucial for left ventricular assist device (LVAD) implantation.
- These models aid in candidate selection, quality improvement initiatives, and provider performance evaluation.
- This study focused on developing a 90-day mortality risk model using The Society of Thoracic Surgeons National Intermacs Database (STS Intermacs).
Purpose of the Study:
- To develop and validate a statistical risk model for predicting 90-day mortality after durable LVAD implantation.
- To assess the model's performance in terms of discrimination and calibration.
- To enable the calculation of observed-to-expected mortality ratios for individual centers.
Main Methods:
- Utilized The Society of Thoracic Surgeons National Intermacs Database (STS Intermacs) for primary durable LVAD implants (January 2019 - September 2023).
- Employed multivariable logistic regression on derivation (2019-2021) and validation (2022-2023) cohorts to build the risk model.
- Assessed model performance using C-statistics (AUC), Brier scores, and calibration plots; calculated observed-to-expected (O/E) ratios for centers.
Main Results:
- The study included 11,342 patients, with 90-day mortality at 8.0% overall (9.2% derivation, 7.4% validation).
- The derived logistic regression model demonstrated similar discrimination (AUC 0.714 and 0.707) and calibration (Brier score 0.08 vs. 0.07) in both cohorts.
- Observed-to-expected analysis identified 22 centers with significantly worse and 14 centers with significantly better than expected mortality.
Conclusions:
- The STS Intermacs risk model exhibits satisfactory discrimination and calibration for predicting 90-day mortality after LVAD implantation.
- This validated tool can inform patient selection for LVADs.
- The model serves as a valuable resource for quality improvement and assessing provider performance in LVAD centers.

